^[1]    Blaschke AJ et al. A National Study of the Impact of Rapid Influenza Testing on Clinical Care in the Emergency Department. J Pediatric Infect Dis Soc. 2014 Jun;3(2):112-118. Epub 2013 Nov 13J Pediatric Infect Dis Soc. 2014 Jun;3(2):112-118. Epub 2013 Nov 13
^[2]    Bell J et al. Clincal Evaluation of the Alere™ i Influenza A&B Assay, a point-of-care rapid nucleic acid amplification test for detection of influenza. Poster, 29th Clinical Virology Symposium (2013), Daytona Beach, USA
^[3]    Aledort JE et a. Non-pharmaceutical public health interventions for pandemic influenza: an evaluation of the evidence base. BMC Public Health. 2007 Aug 15;7:208.
^[4]    Epidemiologisches Bulletin 28, 2015: www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2015/28/Tabelle.html
^[5]    Van Ness J et al. Isothermal reactions for the amplification of oligonucleotides. Proc Natl Acad Sci U S A. (2003) Apr 15;100(8):4504-9. Epub 2003 Apr 4
^[6]    Craw P, Balachandran W. Isothermal nucleic acid amplification technologies for point-of-care diagnostics: a critical review. Lab Chip (2012) Jul 21;12(14):2469-86. Epub 2012 May 16.